Odenwald Matthew A, Roth Hannah F, Reticker Anesia, Segovia Maria, Pillai Anjana
Department of Medicine, Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, Chicago, USA.
Department of Pharmacy, University of Chicago Medicine, Chicago, USA.
Clin Transplant. 2023 Oct;37(10):e15085. doi: 10.1111/ctr.15085. Epub 2023 Aug 7.
The number of liver transplants (LT) performed worldwide continues to rise, and LT recipients are living longer post-transplant. This has led to an increasing number of LT recipients requiring lifelong care. Optimal care post-LT requires careful attention to both the allograft and systemic issues that are more common after organ transplantation. Common causes of allograft dysfunction include rejection, biliary complications, and primary disease recurrence. While immunosuppression prevents rejection and reduces incidences of some primary disease recurrence, it has detrimental systemic effects. Most commonly, these include increased incidences of metabolic syndrome, various malignancies, and infections. Therefore, it is of utmost importance to optimize immunosuppression regimens to prevent allograft dysfunction while also decreasing the risk of systemic complications. Institutional protocols to screen for systemic disease and heightened clinical suspicion also play an important role in providing optimal long-term post-LT care. In this review, we discuss these common complications of LT as well as unique considerations when caring for LT recipients in the years after transplant.
全球范围内进行的肝移植(LT)数量持续上升,肝移植受者移植后的生存期也在延长。这导致需要终身护理的肝移植受者数量不断增加。肝移植后的最佳护理需要密切关注移植器官以及器官移植后更常见的全身问题。移植器官功能障碍的常见原因包括排斥反应、胆道并发症和原发性疾病复发。虽然免疫抑制可预防排斥反应并降低某些原发性疾病复发的发生率,但它会产生有害的全身影响。最常见的是,这些影响包括代谢综合征、各种恶性肿瘤和感染的发生率增加。因此,优化免疫抑制方案以预防移植器官功能障碍同时降低全身并发症的风险至关重要。筛查全身疾病的机构规程和提高临床怀疑度在提供最佳的肝移植后长期护理中也发挥着重要作用。在本综述中,我们讨论了肝移植的这些常见并发症以及移植后数年护理肝移植受者时的特殊注意事项。